Plenary Panel – #MeToo movement, systems of power and sexual health and wellbeing: Broadening the #MeToo movement
Irin Carmon, New York Magazine & CNN Contributor, New York, USA
Rebecca Thurston, University of Pittsburgh, Pittsburgh, USA

Global trends in HIV in the era of combination prevention – what progress have we made towards elimination?
Wafaa El-Sadr
Columbia University, New York, USA

Mathematical modelling, a luxury or a necessity in STD control?
Geoff Garnett
Bill & Melinda Gates Foundation, Seattle, USA

Understanding chlamydia pathogenesis
Kevin Hybiske
University of Washington, Seattle, USA

The role of key population-led health services in addressing the challenge of STI and HIV
Rena Janamnuaysook
The Thai Red Cross AIDS Research Center, Bangkok, Thailand

Revising STI treatment guidelines in times of rapidly evolving antimicrobial resistant STIs
Jørgen Jensen
Statens Serum Institut, Copenhagen, Denmark

Engaging indigenous communities in health programs
Charlotte Loppie
University of Victoria, Victoria, Canada

Identification and management of complicated syphilis
Christina Marra
University of Washington, Seattle, USA

Overview on the development of point-of-care tests for detection of antimicrobial resistance – challenges and opportunities
Johan Melendez
Johns Hopkins University, Baltimore, USA

Global health legacies, sustainable development goals, and implications for sexual & reproductive health
David Peters
Johns Hopkins University, Baltimore, USA

Priorities for research and programmes for trans communities
Tonia Poteat
University of North Carolina, Chapel Hill, USA

The role of genomics in the diagnosis and management of STIs
Helena Seth-Smith
University Hospital Basel, Basel, Switzerland

The global HIV response at 40
David Wilson
World Bank, Washington, DC, USA